Genova Diagnostics Appoints Keith Meadors as Chief Commercial Officer to Drive Next Phase of Growth

Genova Diagnostics

Genova Diagnostics appointed Keith Meadors, MBA, MT(ASCP), as Chief Commercial Officer for commercial growth leadership. The company pioneers advanced diagnostic testing and strengthens its position in the diagnostics market. He joins at a pivotal time as Genova expands commercial capabilities and momentum. Keith Meadors brings over thirty years of experience across clinical diagnostics, pharmaceuticals, and medical devices. He has a strong record in disciplined growth and high-performing healthcare organizations.

Most recently, Meadors served as Vice President and General Manager at Labcorp for the South Atlantic region. He was responsible for complete profit and loss and regional management. He spearheaded growth initiatives aimed at developing partnerships and boosting market share via innovation in diagnostics. Meadors transformed operations, improved revenue performance, enhanced productivity, and improved customer experience. Prior to this, he served in various leadership positions at Precipio, Fresenius Kabi, Hospira, Pfizer company, and Becton Dickinson.

Commercial Strategy Expansion and Market Growth Focus

Meadors will lead Genova Diagnostics commercial organization, driving growth strategy, customer relationships, diagnostic portfolio expansion, and global market presence.

“Keith brings an exceptional combination of commercial leadership, operational discipline, and deep healthcare experience,” said Jeffrey Ledford, Chief Executive Officer of Genova Diagnostics. “As Genova continues to grow and evolve, we are excited to welcome a proven leader who understands how to build strong teams, create meaningful customer partnerships, and drive long-term value for the organization.”

Genova acquired Cell Science Systems in January 2026. This strengthened its diagnostic position and expanded innovation opportunities significantly further. Supporting next phase growth. Levine Leichtman Capital Partners supports continued investment.

“Genova Diagnostics has built a strong reputation for scientific rigor, innovation, and service,”said Meadors. “I’m honored to join the company at such an important time and look forward to working with the team to build on that foundation, expand our commercial impact, and help more customers access the value Genova brings to the market.”

For more stories on executive leadership and business innovations, explore our CXO Insiders for the latest updates.

Source:  PRNewswire

Share with friends

Latest News